Gene Mutation of Interleukin-2 Receptor Common Gamma Chain in Four Male Infants with X-Linked Severe Combined Immunodeficiency

doi:10.3877/cma.j.issn.1673-5250.2014.03.016

Objective

To analyse the relationship between clinical manifestations and the mutation of interleukin-2 receptor common gamma chain (IL-2RG) mutation of X-linked severe combined immunodeficiency (SCID) caused by IL-2RG.

Methods

From May 2010 to September 2012, four boys who were clinically suspected as X-linked SCID were enrolled in this study. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of West China Second University Hospital, Sichuan University.Informed consent was obtained from each participants' parents. IL-2RG mutation were detected and analyzed in four patients and their family members.

Results

Four boys were all suffered by severe pulmonary infection (severe pneumonia) and demonstrated to have absence of thymus or dysplastic thymus by chest X-ray film. Among them, three patients had tuberculosis infection after bacilli Calmette-Guerin (BCG) vaccination (75%), two patients had family history (50%), and all patients suffered lymphopenia (100%). All 4 male infants were demonstrated to be X-linked SCID due to the mutation of IL-2RG, including 2 patients with nonsense mutations (50%, c. 711.G>A, p. W237X and c. 578.G>A, p. W193X, respectively), one missense mutation (25%, c. 173C>A, p. P58Q), and 1 splice site mutation (25%, IVS5-2 G>T). The linear relatives of 3 patients and maternal relatives were detected the mutation of IL-2RG, and 3 patients were demonstrated to have family carriers (75%) and one patient was suffered by de novo mutation (25%).

Conclusions

The detection of IL-2RG gene mutation can confirm clinical diagnosis of X-linked SCID which is critical for patients to take hematopoietic stem cell transplantation as soon as possible to reconstruction of immunity before the fatal infection occurred. The early immune reconstruction can offer the best chance of long term survival.

Key words: Severe combined immunodeficiency, Receptors, interleukin-2, Mutation

表1 4例患儿的临床特征

Table 1 Clinical characterizations of four infants with X-linked SCID

序号	性别	起病年龄(d)	诊断年龄(d)	重症肺炎	持续腹泻	胸腺	PPD皮试	卡介苗接种	家族病史
患儿1	男	120	178	有	有	显著缩小	阴性	接种部位化脓	有^b
患儿2	男	97	141	有	有	无胸腺	阴性	全身散播性结核感^a	无
患儿3	男	171	213	有	无	无胸腺	阴性	接种部位红肿、破溃	无
患儿4	男	89	102	有	有	无胸腺	阴性	接种部位未见异常^c	有^d

表1 4例患儿的临床特征

Table 1 Clinical characterizations of four infants with X-linked SCID

序号	性别	起病年龄(d)	诊断年龄(d)	重症肺炎	持续腹泻	胸腺	PPD皮试	卡介苗接种	家族病史
患儿1	男	120	178	有	有	显著缩小	阴性	接种部位化脓	有^b
患儿2	男	97	141	有	有	无胸腺	阴性	全身散播性结核感^a	无
患儿3	男	171	213	有	无	无胸腺	阴性	接种部位红肿、破溃	无
患儿4	男	89	102	有	有	无胸腺	阴性	接种部位未见异常^c	有^d

表2 4例患儿血常规检测结果(×10⁹/L)

Table 2 Results of complete blood count of four infants with X-linked SCID(×10⁹/L)

序号	WBC计数	中性粒细胞	淋巴细胞	Hb(g/L)	PLT计数
患儿1	4.50～7.20	3.08～5.47	0.54～0.86	74.00～90.00	283.00～376.00
患儿2	2.20	1.54	0.15	119.00	35.00
患儿3	8.80	6.10	2.50	122.00	279.00
患儿4	7.30	5.48	1.39	102.00	483.00

表2 4例患儿血常规检测结果(×10⁹/L)

Table 2 Results of complete blood count of four infants with X-linked SCID(×10⁹/L)

序号	WBC计数	中性粒细胞	淋巴细胞	Hb(g/L)	PLT计数
患儿1	4.50～7.20	3.08～5.47	0.54～0.86	74.00～90.00	283.00～376.00
患儿2	2.20	1.54	0.15	119.00	35.00
患儿3	8.80	6.10	2.50	122.00	279.00
患儿4	7.30	5.48	1.39	102.00	483.00

表3 4例患儿免疫学检测结果(%)

Table 3 Results of immunology detection of four infants with X-linked SCID(%)

序号	CD₃	CD₄	CD₈	CD₁₉⁺	CD₁₆⁺/CD₅₆⁺	IgG(g/L)	IgA(g/L)	IgM(g/L)	IgE(IU/mL)
患儿1	0.00(50.00～84.00)	0.00(27.00～51.00)	0.00(15.00～44.00)	68.00(5.00～18.00)	29.00(7.00～40.00)	6.60(3.05～8.87)	0.14(0.11～0.45)	0.19(0.31～0.85)	2.60(<150.00)
患儿2	0.30(48.00～75.00)	0.20(33.00～58.00)	0.10(11.00～25.00)	75.00(14.00～39.00)	0.10(2.00～14.00)	8.13(2.60～6.90)	0.15(0.03～0.82)	0.12(0.15～1.09)	1.50(0.00～7.20)
患儿3	0.15(64.62～77.80)	0.07(32.69～44.23)	0.02(24.81～35.99)	91.70(6.38～12.46)	1.67(14.40～30.27)	3.90(4.10～10.80)	179.00(130.00～820.00)	591.00(480.00～2 280.00)	8.00(<150.00)
患儿4	3.70(48.00～75.00)	0.90(33.00～58.00)	2.60(11.00～25.00)	92.10(14.00～39.00)	1.40(2.00～14.00)	6.34(2.60～6.90)	0.03(0.03～0.82)	0.59(0.15～1.09)	241.4(0.00～7.20)

表3 4例患儿免疫学检测结果(%)

Table 3 Results of immunology detection of four infants with X-linked SCID(%)

序号	CD₃	CD₄	CD₈	CD₁₉⁺	CD₁₆⁺/CD₅₆⁺	IgG(g/L)	IgA(g/L)	IgM(g/L)	IgE(IU/mL)
患儿1	0.00(50.00～84.00)	0.00(27.00～51.00)	0.00(15.00～44.00)	68.00(5.00～18.00)	29.00(7.00～40.00)	6.60(3.05～8.87)	0.14(0.11～0.45)	0.19(0.31～0.85)	2.60(<150.00)
患儿2	0.30(48.00～75.00)	0.20(33.00～58.00)	0.10(11.00～25.00)	75.00(14.00～39.00)	0.10(2.00～14.00)	8.13(2.60～6.90)	0.15(0.03～0.82)	0.12(0.15～1.09)	1.50(0.00～7.20)
患儿3	0.15(64.62～77.80)	0.07(32.69～44.23)	0.02(24.81～35.99)	91.70(6.38～12.46)	1.67(14.40～30.27)	3.90(4.10～10.80)	179.00(130.00～820.00)	591.00(480.00～2 280.00)	8.00(<150.00)
患儿4	3.70(48.00～75.00)	0.90(33.00～58.00)	2.60(11.00～25.00)	92.10(14.00～39.00)	1.40(2.00～14.00)	6.34(2.60～6.90)	0.03(0.03～0.82)	0.59(0.15～1.09)	241.4(0.00～7.20)

表4 4例患儿IL-2RG基因突变测定结果

Table 3 The gene mutations of IL-2RG of four infants with X-SCID

序号	突变部位	基因突变	氨基酸异常	突变类型	家族携带者
患儿1	Exon5	g.2559.G>A；c.711.G>A	p.W237X	无义突变	母亲、姐姐、姨妈、表姐
患儿2	Exon4	g.2426.G>A；c.578.G>A	p.W193X	无义突变	母亲
患儿3	Exon2	g.840C>A；c.173C>A	p.P58Q	错义突变	无
患儿4	Intron5	IVS5-2 G>T	－	拼接位点突变	母亲

表4 4例患儿IL-2RG基因突变测定结果

Table 3 The gene mutations of IL-2RG of four infants with X-SCID

序号	突变部位	基因突变	氨基酸异常	突变类型	家族携带者
患儿1	Exon5	g.2559.G>A；c.711.G>A	p.W237X	无义突变	母亲、姐姐、姨妈、表姐
患儿2	Exon4	g.2426.G>A；c.578.G>A	p.W193X	无义突变	母亲
患儿3	Exon2	g.840C>A；c.173C>A	p.P58Q	错义突变	无
患儿4	Intron5	IVS5-2 G>T	－	拼接位点突变	母亲

1	Stephan JL, Vlekova V, Le Deist F, et al.Severe combined immunodeficiency:a retrospective single-center study of clinical presentation and outcome in 117 patients[J].J Pediatr, 1993, 123(4):564-572.
2	Warrell DA, Cox TM, Firth JD, ed. Oxford textbook of medicine.5th ed[M].Oxford: Oxford University Press, 2010:1-53.
3	Agarwal S, Mayer L.Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency[J].Clin Gastroenterol Hepatol, 2013, 11(9):1050-1063.
4	Zhang C, Zhang ZY, Wu JF, et al.Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China[J]. World J Pediatr, 2013, 9(1):42-47.
5	Lipstein EA, Vorono S, Browning MF, et al.Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency[J].Pediatrics, 2010, 125(5):1226-1235.
6	Sugamura K, Asao H, Kondo M, et al.The interleukin-2 receptor chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID[J].Annu Rev Immunol, 1996, 14:179-205.
7	Rhim JW, Kim QH, Kim DS, et al. Prevalence of primary immunodeficiency in Korea[J]. J Korean Med Sci, 2012, 27(7):788-793.
8	Speckmann C, Pannicke U, Wiech E, et al. Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency[J].Blood, 2008, 112(10):4090-4097.
9	Noguchi M, Yi H, Rosenblatt HM, et al.Interleukin-2 receptor g chain mutation results in X-linked severe combined immunodeficiency in humans[J].Cell, 1993, 73(1):147-157.
10	Puck JM, Deschenes SM, Porter JC, et al.The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1[J].Hum Mol Genet, 1993, 2(8):1099-1104.
11	Kovanen PE, Leonard WJ.Cytokines and immunodeficiency diseases:critical roles of the gamma(C)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways[J].Immunol Rev, 2004, 202:67-83.
12	Horino S, Uchiyama T, So T, et al.Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector[J].PLoS One, 2013, 8(8):71594.
13	Buckley RH, Schiff RI, Schiff SE, et al.Human severe combined immunodefi ciency: genetic, phenotypic, and functional diversity in one hundred eight infants[J].J Pediatr, 1997, 130(3):378-387.
14	DiSanto JP, Rieux-Laucat F, Dautry-Varsat A, et al.Defective human interleukin 2 receptor γ chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells[J].Proc Natl Acad Sci USA, 1994, 91(20):9466-9470.
15	Kawai T, Saito M, Nishikomori R, et al.Mutation analysis of IL-2RG in human X-linked severe combined immunodeficiency[J].J Clin Immunol, 2012, 32(4):690-697.
16	De Ravin SS, Malech HL.Partially corrected X-linked severe combined immunodeficiency: long-term problems and treatment options[J]. Immunol Res, 2009, 43(1-3):223-242.
17	Mukherjee S, Thrasher AJ. Gene therapy for PIDs: progress, pitfalls and prospects[J].Gene, 2013, 525(2):174-181.
18	Yi Y, Noh MJ, Lee KH.Current advances in retroviral gene therapy[J]. Curr Gene Ther, 2011, 11(3):218-228.
19	Buckley RH, Schiff SE, Schiff RI, et al.Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency[J].N Engl J Med, 1999, 340(7):508-516.
20	Myers LA, Patel DD, Puck JM, et al.Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival[J].Blood, 2002, 99(3):872-878.
21	Burroughs L, Woolfrey A.Hematopoietic cell transplantation for treatment of primary immune deficiencies[J].Cell Ther Transplant, 2010, 2(8):1-22.
22	Kumaki S, Sasahara Y, Kamachi Y, et al. B-cell function after unrelated umbilical cord blood transplantation using a minimal-intensity conditioning regimen in patients with X-SCID[J]. Int J Hematol, 2013, 98(3):355-360.

[1]	Xiaoling Tie, Yi Liu, Ying Yang, Fengyu Che. Clinical features and genetic analysis of Rubinstein-Taybi syndrome：three cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(04): 452-459.
[2]	Li Wang, Lei Cao, Yadan Wang, Wei Zhang. Krabbe disease: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(03): 339-345.
[3]	Ming Wu, Fenhua Zhu, Danru Liu, Yeheng Yu, Tong Lin, Jian Li. Children mucolipidosis caused by GNPTAB/GNPTG gene mutations: two cases report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 185-191.
[4]	Hexuan Zhang, Xue Yang, Lyujin Wang, Linjie Li, Xingyu Liu. Screening and genetic mutation analysis of glucose-6-phosphate dehydrogenase deficiency in neonates[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2024, 20(02): 200-208.
[5]	Ying Huang, Xuan Li, Mengyang Liu, Guilin Peng, Xin Xu, Bing Wei, Chao Yang. Targeted combination therapy for advanced lung adenocarcinoma with double mutation of KRAS and BRAF genes after double lung transplantation：a case report[J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 298-301.
[6]	Yun Liu, Yue Shi, Dongmei Guo, Zhiyuan Qiu, Lijuan Wang, Xuehong Ran, Qianpeng Li. Treatment of myeloid neoplasm with germline mutation by hematopoietic stem cell transplantation:three cases and literature review[J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(04): 230-234.
[7]	Miao Lai, Xin Jing, Guizhen Li, Yi Li. Clinicopathological and prognostic significance of EGFR mutant subtypes in patients with non-small cell lung cancer[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(05): 731-737.
[8]	Qi Zheng, Jiequn Ma, Yanbing Zhang, Zijun Liao, Rui Zhang. Clinical value of EPHA5 mutation in predicting the prognosis of lung adenocarcinoma treated with immune checkpoint inhibitors[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(04): 548-552.
[9]	Wenzhu Liu, Yao Tang, Fuchen Liu. Advances in the application of induced pluripotent stem cells in neuromuscular diseases[J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2024, 14(06): 367-373.
[10]	Mingzheng Chen, Yulong Li, Liukang Tang, Feng Xie. Research progress in IDH1 mutation in treatment of intrahepatic cholangiocarcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(01): 103-108.
[11]	Bin Lu, Tianqi Zhang, Ye Xu, Fangqi Liu. Clinicopathological and molecular characteristics of classical familial adenomatous polyposis in the Chinese population[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(01): 38-44.
[12]	Dayang Zhou, Chang Liu, Jian Huang, Ning Xu, Xiang Ji, Kexin Yang, Jibang Peng, Hai Pan, Wenjing Xu, Zhu Zhu. A casereport of BRCA1 p.R166fs mutation in colon cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(01): 68-71.
[13]	Yao Yao, Yang Gao, Junqi Shan, Xinyu Li, Wei Han, Zengjun Li, Yanlai Sun. A case report of c.531+6T>G heterozygous mutation in familial adenomatous polyposis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(01): 72-77.
[14]	Donglei Zhang, Xiaoyan Liu, Sanyun Wu, Yi Zhou, Xian Zhang. Clinical and genetic analysis of a inherit factor Ⅻ deficiency pedigree and analysis of factor Ⅻ deficiency in the Chinese population[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2024, 12(03): 162-169.
[15]	Teng Zhang, Yanling Tao. A case of secondary myelodysplastic syndrome in a patient with Shwachman-Diamond syndrome and literature review[J]. Chinese Journal of Diagnostics(Electronic Edition), 2024, 12(03): 178-182.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export